Overlooking the Covid-19 cases so far the results look promising.
Our products are in high demand and many questions are being raised.
Find out more about how we are helping during the COVID-19 pandemic.
FCV® technology has shown in (clinical) studies a higher efficient ventilation with improved lung mechanics and reduced lung damage as compared to conventional methods. FCV® controls both the inspiration and expiration phase and can be applied through regular endotracheal tubes and our ultrathin Tritube.
Small-bore endotracheal ventilation tube
Flexible 2 mm catheter
Dutch Ministry of Health also opts for Evone® by Ventinova from Eindhoven Results of FCV®-equipped ventilation equipment appears promising Eindhoven, 2 April 2020 – Ventinova Medical, a company based in Eindhoven, received good news today; this concerns...